Suchergebnisse - (Subject:"Siltuximab")

PubPharm (74)

1

Population pharmacokinetics of siltuximab : impact of disease state

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Nikanjam, M. | Yang, J. | Capparelli, E.

2

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Brighton, T. | Khot, A. | Harrison, S. | +15

3

Remission of Refractory Systemic-Onset Juvenile Idiopathic Arthritis After Treatment With Siltuximab

enthalten in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases | 2019

von Leurs, A. | Launay, D. | Terriou, L. | +3

4

Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease : secondary analyses of phase II clinical trial data

enthalten in: British journal of haematology | 2019

von Morra, D. | Pierson, S. | Shilling, D. | +6

5

Recent advances in pediatric non-Hodgkin lymphoma. Report on a retrospective single-center cohort and review of the literature

enthalten in: Magyar onkologia | 2018

von Szegedi, I. | Gáspár, I. | Gyurina, K. | +2

6

The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2018

von Masjedi, A. | Hashemi, V. | Hojjat-Farsangi, M. | +4

7

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Hematology. American Society of Hematology. Education Program | 2018

von Fajgenbaum, D.

8

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von Fajgenbaum, D.

9

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von van Rhee, F. | Voorhees, P. | Dispenzieri, A. | +39

CommentIn: Blood. 2018 Nov 15;132(20):2109-2110. - PMID 30442745

10

Siltuximab in relapsed/refractory multicentric Castleman disease : Experience of the Italian NPP program

enthalten in: Hematological oncology | 2018

von Tonialini, L. | Bonfichi, M. | Ferrero, S. | +4

1
2
3
4
5
6
7
8
Nächster »
[8]